The company AstraZeneca It will stop marketing its vaccine against Covid-19, Vaxzevria, starting tomorrow, Tuesday, in the European Union at its own request, according to the British-Swedish company in a statement.
The European Commission notified on March 27 that, at the request of the owner – AstraZeneca –, it is withdrawing the marketing authorization of the drug as of tomorrow, Tuesday.
AstraZeneca The withdrawal is justified by the lack of demand and the surplus of vaccines currently available on the market.
“As multiple updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has led to a decrease in demand for Vaxzervria, which is no longer manufactured or supplied“, is noted in the note.
The laboratory, which made the withdrawal request on March 5 before Brussels, congratulates itself on the role played by Vaxzevria to end the pandemic. In this line he points out that, “According to independent estimates, more than 6.5 million lives were saved and more than 3 billion doses were delivered worldwide in the first year of use alone.”.
Vaxzevriathe vaccine AstraZeneca against covid-19, it was the third to arrive in Spain, on February 6, 2021, once authorized by the European Comission on January 29 of that year after the review to which all vaccines undergo by the European Medicines Agency.
It was the third vaccine to receive approval from European regulators, after those made by Pfizer/BioTech and modern.
Source: Gestion
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
